Related Experiment Video
Updated: Nov 14, 2025

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
Published on: June 13, 2025
Primary prophylaxis of gastric variceal bleeding: endoscopic obturation, radiologic intervention, or observation?
Jung Wan Choe1, Hyung Joon Yim2, Seung Hwa Lee3
1Department of Internal Medicine, Korea University College of Medicine, Korea University Ansan Hospital, 123, Jeokgeum-ro, Danwon-gu, Ansan, Gyeonggi-do, 15355, Korea.
Insights
Endoscopic variceal obturation (EVO) and balloon-occluded retrograde transvenous obliteration (BRTO) effectively prevent gastric varices bleeding. BRTO shows superior eradication rates compared to EVO.
Area of Science:
- Gastroenterology
- Hepatology
- Interventional Endoscopy
Background:
- Gastric varices (GV) pose a bleeding risk in liver cirrhosis patients.
- Effective primary prophylaxis for gastric varices remains elusive.
Purpose of the Study:
- To evaluate the efficacy of endoscopic variceal obturation (EVO) and balloon-occluded retrograde transvenous obliteration (BRTO) in preventing gastric varices bleeding.
- To compare the complete eradication rates of GV between EVO and BRTO.
Main Methods:
- Retrospective analysis of liver cirrhosis patients with GV.
- Comparison of prophylactic treatments: EVO, BRTO, and clinical observation.
- Endpoints: GV bleeding rate and complete eradication rate.
Main Results:
- EVO and BRTO significantly reduced GV bleeding compared to observation (p<0.05).
- BRTO demonstrated a higher complete eradication rate (75.6%) than EVO (45.8%) (p=0.003).
- Complete eradication of GV was the sole predictor of reduced bleeding risk.
Conclusions:
- EVO and BRTO are safe and effective prophylactic treatments for gastric varices.
- BRTO is more effective than EVO for complete eradication of gastric varices.
Background:
No single effective method has yet been established for the primary prophylaxis of bleeding from gastric varices (GV).
Methods:
We retrospectively analyzed liver cirrhosis patients with GV who had undergone either endoscopic variceal obturation (EVO) or balloon-occluded retrograde transvenous obliteration (BRTO) as prophylactic treatments, comparing them with those who were observed without any procedural intervention. The endpoints were GV bleeding rate and complete eradication rate.
Results:
72 patients in EVO, 41 patients in BRTO, and 97 patients in the clinical observation groups were enrolled. No difference was observed in baseline characteristics. As the primary endpoint, 14 (19.4%) patients in the EVO group and 3 (7.3%) in the BRTO group bled from GV after prophylactic treatment, and 34 (35.1%) patients bled in the observation group during the median follow-up of 35 months (p = 0.001). Patients who received EVO or BRTO developed less bleeding from GV than those who received observation only, with no difference between EVO and BRTO (EVO vs. observation, p = 0.038; BRTO vs. observation, p = 0.001; EVO vs. BRTO, p = 0.089). As secondary endpoints, GV disappeared completely in 33 patients (45.8%) in the EVO group and 31 patients (75.6%) in the BRTO group (p = 0.003). By multivariate analysis, complete eradication of GV was the sole determinant for predicting GV bleeding.
Conclusions:
EVO and BRTO are effective and safe primary prophylactic treatments for preventing bleeding from GV. In particular, BRTO is better than EVO in complete eradication of GV.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Esophageal Varices-I: Introduction
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Endoscopic Procedures V: ERCP
Patient...

